Sell your Medicare home health agency

What drives a home health valuation

The certification itself carries value, but buyers pay for performance behind it. Episodic margin, visit utilization per 30 day period, LUPA rate, and therapy mix tell a buyer whether your clinical model survives contact with their cost structure.

PDGM performance

Revenue per period, LUPA percentage, and coding accuracy across your top diagnosis groups.

Quality scores

Star ratings, HHCAHPS results, and rehospitalization performance shape both price and payer leverage.

Survey and compliance record

Accreditation status, condition level findings, and any additional documentation requests.

Referral base

Hospital, skilled nursing, and physician relationships, and how concentrated they are.

Change of ownership is part of the deal, not an afterthought

Medicare change of ownership treatment affects structure, timing, and sometimes price. Buyers plan around whether the provider agreement is assigned or a new enrollment is required, and around state licensure and certificate of need rules where they apply.

Experienced home health acquirers handle this constantly. That is the main reason owners come to us rather than negotiating with the first interested party: a buyer who has closed ten home health deals will not stall at the regulatory step.

Who buys home health agencies

Three groups compete: regional home health platforms adding density, private equity backed groups building multi state coverage, and payer or provider aligned buyers who want post acute control in a specific market. Each values your agency differently, which is exactly why speaking with several beats accepting the one email in your inbox.

Medicare Compliance and the 36-Month Rule

Home health agencies (HHAs) face strict Medicare regulations that can dictate the timing of a sale. Specifically, the CMS 36-month rule can prevent a Medicare agreement from conveying if more than 50% of direct ownership changes within 36 months of enrollment or the last majority change. This rule is designed to prevent the 'flipping' of agencies and requires sellers to have a long-term operational history before seeking an exit.

Buyers will scrutinize your Patient-Driven Groupings Model (PDGM) performance. Since PDGM uses 30-day payment periods and 432 case-mix groups, your clinical documentation must be precise to capture the correct reimbursement. The CMS CY2025 final rule projected a modest aggregate payment increase of 0.5%, but it included a permanent -1.975% behavior adjustment, making operational efficiency more critical than ever for valuation.

Valuing Skilled Home Health Assets

Valuation in the skilled sector often hinges on the quality of the clinical staff and the referral network. In July 2024, Pennant agreed to acquire Signature Healthcare at Home assets for $80 million. The disclosed metrics included approximately $78 million in trailing revenue and over 12,000 home health admissions. This represents a valuation of roughly 1.03x revenue. Note that terms for many smaller deals are not disclosed, and multiples vary wildly based on market share.

When assessing value, distinguish between your enterprise value and your net proceeds. Enterprise value is the total value of the business, while equity proceeds are what you keep after paying off debt and adjusting for working capital. Do not rely on public company trading multiples as they do not reflect the liquidity risks or lack of diversification inherent in a single-location private agency.

Due Diligence and Payer Adjustments

During due diligence, buyers will perform a 'Quality of Earnings' (QofE) report. This involves stripping out non-recurring items and ensuring that revenue is recognized correctly under accrual accounting. They will also look at your 'ZPIC' or 'UPIC' audit history. Any unresolved audits can stall a deal or lead to significant funds being placed in an escrow account for several years to cover potential clawbacks.

The transaction process begins with a Confidential Information Memorandum (CIM), moves to an Expression of Interest (EOI), and culminates in a Letter of Intent (LOI). Sellers should be cautious and seek specialized financial advice to ensure they are not left with unfavorable terms in the definitive purchase agreement. This guide is for informational purposes and does not constitute legal advice.